Filing Details
- Accession Number:
- 0000933430-22-000001
- Form Type:
- 13G Filing
- Publication Date:
- 2022-01-23 19:00:00
- Filed By:
- Whitmore Bradford T
- Company:
- Clearside Biomedical Inc.
- Filing Date:
- 2022-01-24
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
BRADFORD T. WHITMORE | 3,529,845 | 2,348,352 | 3,529,845 | 2,348,352 | 5,878,197 | 9.9% |
GRACE BROTHERS | 2,348,352 | 2,348,352 | 2,348,352 | 3.9% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G/A
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Clearside Biomedical, Inc.
-----------------------------------------
(Name of Issuer)
Common Stock, $.001 par value
-----------------------------------------
(Title of Class Securities)
185063104
-----------------------------------------
(CUSIP Number)
December 31, 2021
-----------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
/ / Rule 13d-1(b)
/X/ Rule 13d-1(c)
/ / Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover
page shall not be deemed to be "filed" for the purpose of
Section 18 of the Securities Exchange Act of 1934 ("Act")
or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
3
SCHEDULE 13G/A
CUSIP NO. 185063104 PAGE 3 OF 6 PAGES
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS
(ENTITIES ONLY).
GRACE BROTHERS, LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP(See
Instructions)
(a)/ /
(b)/ /
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware Limited Partnership
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING
PERSON WITH:
5 SOLE VOTING POWER
NONE
6 SHARED VOTING POWER
2,348,352 SHARES
7 SOLE DISPOSITIVE POWER
NONE
8 SHARED DISPOSITIVE POWER
2,348,352 SHARES
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,348,352 SHARES
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES / /
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.9%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
4
Page 4 of 6 Pages
Item 1.
(a) Name of Issuer
Clearside Biomedical, Inc.
(b) Address of Issuer's Principal Executive Offices
900 North Point Parkway, Suite 200, Alpharetta, GA 30005
Item 2.
(a) Name of Person Filing
The statement is filed by Bradford T. Whitmore
("Whitmore") and Grace Brothers, LP ("Grace"). Whitmore
is the General Partner of Grace Brothers, LP.
(b) Address of Principal Business Office or, if none,
Residence
The business address of Whitmore and Grace is
1603 Orrington Avenue, Suite 900, Evanston, IL 60201.
(c) Citizenship
Whitmore is a United States citizen and Grace is a
Delaware limited partnership.
(d) Title of Class of Securities
Common Stock, $.001 par value (the "Common Stock")
(e) CUSIP Number
185063104
Item 3. If this statement is filed pursuant to Sections
240.13d-1(b) or 240.13d-2(b) or (c), check whether the
person filing is a:
(a) ( ) Broker or dealer registered under section 15 of
the Act (15 U.S.C. 78o);
(b) ( ) Bank as defined in section 3(a)(6) of the Act
(15 U.S.C. 78c);
(c) ( ) Insurance company as defined in section 3 (a)(19)
of the Act (15 U.S.C. 78c);
(d) ( ) Investment company registered under section 8 of
the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e) ( ) An investment adviser in accordance with Section
240.13d-1(b)(1)(ii)(E);
(f) ( ) An employee benefit plan or endowment fund in
accordance with Section 240.13d-1(b)(1)(ii)(F);
(g) ( ) A parent holding company or control person in
accordance with Section 240.13d-1(b)(l)(ii)(G);
(h) ( ) A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813);
6
Page 6 of 6 Pages
Item 7. Identification and Classification of the
Subsidiary Which Acquired the Security Being Reported on
By the Parent Holding Company
Reporting person is not a parent holding company.
Item 8. Identification and Classification of Members of
the Group
Reporting person is not a member of a group.
Item 9. Notice of Dissolution of Group
Reporting person is not filing notice of dissolution of
a group.
Item 10. Certification
By signing below Bradford T. Whitmore certifies that, to
the best of my knowledge and belief, the securities
referred to above were acquired and are held in the
ordinary course of business and were not acquired and are
not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with
or as a participant in any transaction having that purpose
or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in
this Statement is true, complete and correct.
January 24, 2022
----------------
Date
Bradford T. Whitmore
by: /s/ Bradford T. Whitmore
----------------------------
Signature
Grace Brothers, LP
by: /s/ Bradford T. Whitmore
----------------------------
Signature
Its: General Partner
--------------------
Title